The Current Ratio as of September 2024 (TTM) for NeoGenomics, Inc. (NEO) is 2.01

According to NeoGenomics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.01. This represents a change of -63.38% compared to the average of 5.50 of the last 4 quarters.

NeoGenomics, Inc. (NEO) Historical Current Ratio (quarterly & annually)

How has NEO Current Ratio performed in the past?

The mean historical Current Ratio of NeoGenomics, Inc. over the last ten years is 4.34. The current 2.01 Current Ratio has changed 4.55% with respect to the historical average. Over the past ten years (40 quarters), NEO's Current Ratio was at its highest in in the March 2021 quarter at 13.91. The Current Ratio was at its lowest in in the December 2016 quarter at 1.32.

NeoGenomics, Inc. (NEO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NeoGenomics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeoGenomics, Inc. (NEO) Average Current Ratio

How has NEO Current Ratio performed in the past?

The current Current Ratio of NeoGenomics, Inc. (NEO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NeoGenomics, Inc. (NEO) Current Ratio vs. Peers

How is NEO’s Current Ratio compared to its peers?

NeoGenomics, Inc.’s Current Ratio is less than Natera, Inc. (4.14), greater than Qiagen N.V. (1.77), less than Neogen Corporation (3.82), less than Guardant Health, Inc. (6.40), less than CareDx, Inc (4.09), greater than Myriad Genetics, Inc. (1.27), less than Invitae Corporation (2.39), less than Castle Biosciences, Inc. (8.12), greater than Syneos Health, Inc. (1.20), greater than Mettler-Toledo International Inc. (0.92), greater than ICON Public Limited Company (1.31), greater than IQVIA Holdings Inc. (0.85), greater than Charles River Laboratories International, Inc. (1.58), less than Sotera Health Company (2.93), less than Olink Holding AB (publ) (5.60), less than Aclaris Therapeutics, Inc. (7.50), less than Twist Bioscience Corporation (4.91), less than Biodesix, Inc. (3.28),

Build a custom stock screener for NeoGenomics, Inc. (NEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoGenomics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeoGenomics, Inc. (NEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeoGenomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.